Pleiotropic functional properties of androgen receptor mutants in prostate cancer-Reference-Cited by-同舟云学术

Pleiotropic functional properties of androgen receptor mutants in prostate cancer

Published:2008-09-17 Issue:2 Volume:30 Page:145-157
ISSN:1059-7794
Container-title:Human Mutation
language:en
Short-container-title:Hum. Mutat.

Author:

Bergerat Jean-Pierre,Céraline Jocelyn

Funder

Hôpitaux Universitaires de Strasbourg

ATGC-Alsace contre le cancer

ARTP

Ligue Nationale contre le Cancer-Comités du Bas-Rhin et du Haut-Rhin

PHRC National

Association pour la Recherche sur le Cancer

Publisher

Wiley

Subject

Genetics(clinical),Genetics

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/humu.20848/fullpdf

Reference140 articles.

1. Mechanisms involved in the progression of androgen-independent prostate cancers: it is not only the cancer cell's fault;Arnold;Endocr Relat Cancer,2002

2. The androgen receptor (AR) in syndromes of androgen insensitivity and in prostate cancer;Avila;J Steroid Biochem Mol Biol,2001

3. Constitutive activation of the Ras/mitogen-activated protein kinase signaling pathway promotes androgen hypersensitivity in LNCaP prostate cancer cells;Bakin;Cancer Res,2003

4. Androgen receptor mediates non-genomic activation of phosphatidylinositol 3-OH kinase in androgen-sensitive epithelial cells;Baron;J Biol Chem,2004

5. Androgen-dependent regulation of Her-2/neu in prostate cancer cells;Berger;Cancer Res,2006

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioinspired Lipid Nanocarriers for RNA Delivery;ACS Bio & Med Chem Au;2023-01-16

2. Dissecting the effects of androgen deprivation therapy on cadherin switching in advanced prostate cancer: A molecular perspective;Oncology Research;2022

3. Nuclear Export Inhibitor KPT-8602 Synergizes with PARP Inhibitors in Escalating Apoptosis in Castration Resistant Cancer Cells;International Journal of Molecular Sciences;2021-06-22

4. Current Status and Future Perspectives of Androgen Receptor Inhibition Therapy for Prostate Cancer: A Comprehensive Review;Biomolecules;2021-03-25

5. T-LAK cell-originated protein kinase (TOPK) enhances androgen receptor splice variant (ARv7) and drives androgen-independent growth in prostate cancer;Carcinogenesis;2020-11-13